<- Go Home
ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Market Cap
$1.4B
Volume
224.9K
Cash and Equivalents
$144.9M
EBITDA
$82.3M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$364.2M
Profit Margin
59.27%
52 Week High
$73.72
52 Week Low
$52.50
Dividend
N/A
Price / Book Value
3.42
Price / Earnings
-67.38
Price / Tangible Book Value
-6.97
Enterprise Value
$1.9B
Enterprise Value / EBITDA
22.78
Operating Income
$14.6M
Return on Equity
4.18%
Return on Assets
0.83
Cash and Short Term Investments
$151.2M
Debt
$630.7M
Equity
$428.5M
Revenue
$614.4M
Unlevered FCF
$49.3M
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium